[HTML][HTML] Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense

MM Leiva-Juárez, JK Kolls, SE Evans - Mucosal immunology, 2018 - Elsevier
Lung epithelial cells are increasingly recognized to be active effectors of microbial defense,
contributing to both innate and adaptive immune function in the lower respiratory tract. As …

Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia

E Lignelli, F Palumbo, D Myti… - American Journal of …, 2019 - journals.physiology.org
Bronchopulmonary dysplasia (BPD) is the most common cause of morbidity and mortality in
preterm infants. A key histopathological feature of BPD is stunted late lung development …

[HTML][HTML] T-helper cells and their cytokines in pathogenesis and treatment of asthma

T Ji, H Li - Frontiers in Immunology, 2023 - frontiersin.org
Prosperous advances in understanding the cellular and molecular mechanisms of chronic
inflammation and airway remodeling in asthma have been made over the past several …

Interleukin‐23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy

C Bridgewood, K Sharif, J Sherlock… - Immunological …, 2020 - Wiley Online Library
The inflammatory disorders collectively termed the seronegative spondyloarthropathies
(SpA) include ankylosing spondylitis (AS), psoriatic arthritis (PsA), reactive arthritis, the …

[HTML][HTML] The airway microbiome-IL-17 axis: a critical regulator of chronic inflammatory disease

JM Mannion, RM McLoughlin, SJ Lalor - Clinical Reviews in Allergy & …, 2023 - Springer
The respiratory tract is home to a diverse microbial community whose influence on local and
systemic immune responses is only beginning to be appreciated. Increasing reports have …

Therapeutic antibodies: A new era in the treatment of respiratory diseases?

T Sécher, L Guilleminault, K Reckamp… - Pharmacology & …, 2018 - Elsevier
Respiratory diseases affect millions of people worldwide, and account for significant levels
of disability and mortality. The treatment of lung cancer and asthma with therapeutic …

[HTML][HTML] The emerging role of IL-23 in asthma and its clinical implications

AY Wu, RS Peebles - Expert Review of Clinical Immunology, 2023 - Taylor & Francis
Asthma is a prevalent, chronic inflammatory respiratory disease defined by airway
hyperresponsiveness (AHR), aberrant mucus production, and airway smooth muscle …

Inhibition of glutaminase 1 activity reverses airway hyperresponsiveness and decreases IL-1β+ M1s and IL-17 producing ILC3s in high-fat diet-fed obese mice

JS Shim, HS Lee, H Kwon, MH Kim… - American Journal of …, 2023 - journals.physiology.org
In obesity, disturbed glutamine metabolism contributes to enhanced inflammation by
inducing alterations in immune cells. As macrophages and innate lymphoid cells (ILCs) are …

[PDF][PDF] Effects of aerobic exercise on molecular aspects of asthma: involvement of SOCS-JAK-STAT.

AO AR, AJ JCJ, OJ MC, AC RW, RO NC, SD LP… - Exercise Immunology …, 2019 - eir-isei.de
Background: Aerobic training (AT) decreases airway inflammation in asthma, but the
underlying cellular and molecular mechanisms are not completely understood. Thus, this …

[HTML][HTML] Innate lymphoid cells in the airways: their functions and regulators

K Orimo, H Saito, K Matsumoto… - Allergy, Asthma & …, 2020 - ncbi.nlm.nih.gov
Since the airways are constantly exposed to various pathogens and foreign antigens,
various kinds of cells in the airways—including structural cells and immune cells—interact to …